Siena Biotech S.P.A.
Records under this name other than patents Siena Biotech S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,329,254 | Process for the Preparation of 6-Chloro-2,3,4,9-Tetrahydro-1H-CARBAZOLE-1-Carboxamide and Intermediates Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,067,926 | FLUOROMETHYL-5,6-Dihydro-4H-[1,3]OXAZINES Formerly held In force · High confidence | In force | High confidence | |
| US 11,472,772 | S1P3 Antagonists Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,951,017 | S1P3 antagonists Formerly held Lapsed on the fee record Ended Apr 24, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 24, 2026 | USPTO record |
| US 9,242,943 | 1,4 Oxazines as BACE1 And/Or BACE2 Inhibitors Formerly held Lapsed on the fee record Ended Jan 26, 2020 · High confidence | Lapsed on the fee record | Ended Jan 26, 2020 | High confidence |
| US 7,989,449 | 4,5-Dihydro-OXAZOL-2-YL Amine Derivatives Formerly held Lapsed on the fee record Ended Aug 2, 2019 · High confidence | Lapsed on the fee record | Ended Aug 2, 2019 | High confidence |
| US 8,987,255 | HALOGEN-ALKYL-1,3 Oxazines as BACE1 And/Or BACE2 Inhibitors Formerly held Lapsed on the fee record Ended Mar 24, 2019 · High confidence | Lapsed on the fee record | Ended Mar 24, 2019 | High confidence |
| US 8,865,704 | Wnt pathway antagonists Lapsed on the fee record Ended Oct 21, 2018 · USPTO record | Lapsed on the fee record | Ended Oct 21, 2018 | USPTO record |
| US 8,835,648 | Hedgehog pathway antagonists and therapeutic applications thereof Lapsed on the fee record Ended Sep 16, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 16, 2018 | USPTO record |
| US 8,815,841 | 1,4-Oxazepines as BACE1 And/Or BACE2 Inhibitors Formerly held Lapsed on the fee record Ended Aug 26, 2018 · High confidence | Lapsed on the fee record | Ended Aug 26, 2018 | High confidence |